AMN Healthcare price target raised to $71 from $60 at BMO Capital

BMO Capital raised the firm’s price target on AMN Healthcare to $71 from $60 and keeps an Outperform rating on the shares after its “margin-driven” Q2 earnings beat. While there is still weakness to work through including winter orders wildcard, AMN management also noted its net win/loss ratio is essentially neutral and showing pipeline improvement, the analyst tells investors in a research note.